Health education of patients with gastrointestinal neoplasia in antineoplastic chemotherapy and quality of life, functional capacity and fatigue
Not Applicable
Recruiting
- Conditions
- Pharmacological treatmentgastrointestinal neoplasmsnursing careChemotherapy, AdjuvantE02.319C04.588.274.476E02.760.611E02.186.170
- Registration Number
- RBR-4zkjfx
- Lead Sponsor
- niversidade Federal do Triângulo Mineiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
The study will include patients diagnosed with CA of the digestive system aged 18 years or older undergoing intravenous antineoplastic chemotherapy treated at the HC / UFTM chemotherapy service. To this end, they agreed to participate in the study by signing the Informed Consent Form, as well as the Free Informed Consent Form prepared according to Resolution 466/12 of the National Health Council (BRAZIL, 2012).
Exclusion Criteria
Will be excluded from the study patients who underwent antineoplastic chemotherapy treatment and / or previous radiotherapy; in adjuvant radiotherapy treatment; diagnosis of metastatic AC, which will perform less than three treatment cycles and / or change chemotherapy protocol during the study.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected to find a reduction and / or a better fatigue score in the intervention group compared to the control group, verified by the Piper Fatigue Scale, the results are presented by percentages used to verify if the outcome actually occurred
- Secondary Outcome Measures
Name Time Method It is expected to find an increase and / or better quality of life score in the intervention group compared to the control group, to be evaluated by the EORTC-QLQ-C30, the results will be presented by percentages used to verify if the outcome actually occurred